FDA Issues Update on Compounding Efforts

The Food and Drug Administration (FDA) has released a report on compounding regulations entitled “FDA’s Human Drug Compounding Progress Report: Three Years After Enactment of the Drug Quality and Security Act (January 2017)”. This document does not provide additional specific information regarding requirements for physician in-office compounding, but does provide a look at what the FDA is working to address. You can read the report here.

The AAAAI, together with the American College of Allergy, Asthma & Immunology, the American Academy of Otolaryngic Allergy and the American Medical Association, continues to vigorously advocate with the FDA, members of Congress and other interested organizations to protect patient access to care by fighting for physician in-office compounding. As always, we encourage you to have a relationship with your elected representatives. If you know any newly elected members of Congress, we would particularly like to speak to you about reaching out to educate that person. You are always welcome to contact us at advocacy@aaaai.org and indicate “compounding” in the subject line.